OrthoTreat

OrthoTreat is dedicated to advancing bone regeneration through innovative solutions that enhance the body's physiological healing mechanisms.

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2020
Last updated 2026-07-23
Total raised
Last: Grant 2024-07
Stage
Seed
Founded
2020
Headcount
11
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

OrthoTreat is a biotechnology company specializing in developing innovative solutions for bone fracture healing, focusing on therapies that enhance and expedite the healing process. Their unique approach, OsteoRegulation, focuses on optimizing biological processes rather than merely providing materials for bone formation, aiming for faster, better, and stronger healing outcomes. Their flagship product, ModulX, is a dual-drug combination administered as a controlled-release, localized injection designed to accelerate healing, improve bone quality, and offer a new level of care for those in need. OrthoTreat also introduces an AI engine that connects bone biology with real-world data, resulting in a smarter way to understand, guide, and optimize the process.

Funding history · 3 rounds · — total

2024-06
Grant Undisclosed
2023-06
Seed Undisclosed
2022-03
Pre-Seed Undisclosed

Headcount over time

From 4 (2021-07) to 11 (2026-03) · +7 (+175%) · 15 points · source: Finder history + radar grounding
120 2021-07 2026-03

Q&A

What is OrthoTreat's primary focus?
OrthoTreat focuses on bone regeneration solutions, aiming to restore strength and resilience to individuals with bone-related conditions through a unique approach that modulates immune response, inflammation, and growth factor secretion.
What is OrthoTreat's flagship product?
OrthoTreat's flagship product is ModulX, a dual-drug combination administered as a controlled-release, localized injection designed to accelerate healing and improve bone quality.
When was OrthoTreat founded?
OrthoTreat was founded in November 2020.
What is the employee count for OrthoTreat?
OrthoTreat has 11-50 employees.
What is the most recent funding event for OrthoTreat?
OrthoTreat received a Grant in July 2024.
Who are the co-founders of OrthoTreat?
The co-founders of OrthoTreat are Sahar Meiron and Hilik Marom.
What is OrthoTreat's current product stage?
OrthoTreat's product is currently in the R&D stage.
Does OrthoTreat hold any patents?
Yes, OrthoTreat holds 1 patent.

Team · 3

Sahar Meiron
Founder · Co-founder & Chief Executive Officer
Dr. Hilik Marom
Founder · Co-founder, Pre-Clinical Research & Innovation Director
Dr. Tami Ehrmann Barr
Founder · Co-founder & Chief Scientific Officer

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business model
B2BB2B2C

Highlights

1 PatentsVerified

Tags

tissue-regenerationdrug-developmentboneorthopedicsmaterialspharmaceuticalsveterinarytherapeuticsnon-invasive
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteorthotreat.io/
LinkedInlinkedin.com/company/70454761

Identifiers & details

Legal nameOrthoTreat Ltd.
Founded2020-11
Employees (exact)11

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainorthotreat.io

Certificate / subdomain footprint

Subdomains4

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516279130
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2020-11-11
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2026
Active charges / liens0
Registry events3 — people (1), shares_capital (1), annual_report (1)
Registered addressהפלך 7 תל אביב - יפו

Recent registry events

DateEvent
2025-11-26עדכון דירקטורים-הוספת דירקטור
2026-02-23הקצאת מניות
2026-01-04דו~ח שנתי